Treatment for Cellulitis in Patients with Amoxicillin Allergy

First-Line Treatment Options

The American College of Physicians recommends clindamycin 300-450 mg orally three times daily as the preferred alternative for patients with penicillin/amoxicillin allergies, providing excellent coverage against both streptococci and staphylococci 1, 2
For patients with non-severe cellulitis, a 5-day course of antimicrobial therapy is typically sufficient if clinical improvement occurs within this timeframe, as suggested by the Infectious Diseases Society of America 3
Doxycycline 100 mg twice daily is another alternative for adults, though it should not be used in children under 8 years of age, according to the Clinical Infectious Diseases guidelines 2
Trimethoprim-sulfamethoxazole (TMP-SMZ) 1-2 double-strength tablets twice daily can be considered, particularly in areas with high MRSA prevalence, as recommended by the Clinical Infectious Diseases society 2

For mild to moderate cellulitis, oral antibiotics are typically sufficient, as stated by the Praxis Medical Insights 3
For severe infections or those with systemic symptoms, consider intravenous clindamycin 600 mg every 8 hours, as suggested by the Clinical Infectious Diseases guidelines 2
Hospitalization is recommended if the patient has systemic inflammatory response syndrome, altered mental status, hemodynamic instability, or signs of deeper infection, according to the Praxis Medical Insights 3

Evaluate response after 48-72 hours of antibiotic therapy, as recommended by the Praxis Medical Insights 3
Extend treatment beyond the initial 5-day period only if the infection has not adequately improved, according to the Praxis Medical Insights 3
Monitor for potential side effects of clindamycin, particularly gastrointestinal symptoms, as suggested by the Praxis Medical Insights 1

Elevate the affected area to promote gravity drainage of edema and reduce inflammation, as recommended by the Praxis Medical Insights 3
Identify and treat any predisposing conditions to prevent recurrence, according to the Praxis Medical Insights 3

Standard treatment for typical cellulitis does not require specific MRSA coverage unless there are risk factors such as purulent drainage, evidence of MRSA infection elsewhere, history of injection drug use, penetrating trauma, or systemic inflammatory response syndrome, as stated by the Praxis Medical Insights 3

Don't extend antibiotic treatment unnecessarily beyond 5 days if clinical improvement has occurred, as recommended by the Praxis Medical Insights 3
Don't automatically assume MRSA coverage is needed for typical non-purulent cellulitis without specific risk factors, according to the Praxis Medical Insights 3
For patients with immediate hypersensitivity reactions to penicillins, avoid cephalosporins due to potential cross-reactivity, as suggested by the Clinical Infectious Diseases guidelines 2